Open AccessShort Time Effect of COVID 19 Pandemic on HbA1c and Acute Metabolic Complications in Children with Type 1 Diabetes
Author(s) -
İlknur Arslanoğlu,
Figen Akcali,
Fatma Yavuzyılmaz,
Mehmet Alı Sungur
Publication year - 2021
Publication title -
sas journal of medicine
Language(s) - English
Resource type - Journals
ISSN - 2454-5112
DOI - 10.36347/sasjm.2021.v07i08.001
Subject(s) - medicine , hypoglycemia , pandemic , diabetes mellitus , diabetic ketoacidosis , ketoacidosis , type 1 diabetes , type 2 diabetes , pediatrics , covid-19 , metabolic control analysis , affect (linguistics) , intensive care medicine , emergency medicine , disease , endocrinology , infectious disease (medical specialty) , linguistics , philosophy
Background: COVID19 pandemic is currently affecting every aspect of daily life of communitiesy throughout the world. We aimed to check how this situation affects the metabolic control of children with type 1 diabetes. Methods: We analyzed all patients with type 1 diabetes a HbA1c test after at least two months ensuing the start of the epidemic in Turkey. We compared the results with the most recent HbA1c test in the hospital’s automation system before the epidemic. In addition, diabetic ketoacidosis (DKA) and severe hypoglycemia rates were compared. Results: Among the eligible 219 cases 77.6% had decreased HbA1c levels according to their former result. Mean drop was about 9.71% compared to the former test in the whole group. Age, sex and time interval between two tests were not found to affect this tendency. Diabetic ketoacidosis rate was the same as before the pandemic, whereas severe hypoglycemia rates increased. Conclusions: Despite the potential of the pandemic to affect routine care of chronic diseases in a negative way the short term metabolic control of type 1 children with type 1 diabetes improved. Telemedicine support by the diabetes team and increased care in the family environment might be possible explanations.